🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Clinical Outcomes of Continuous Positive Airway Pressure Treatment in People With Obstructive Sleep Apnea and Chronic Pain

Recruitingn/aAges 18 Years - anyAllVrije Universiteit Brussel
NCT06834724 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The bidirectional link between sleep and pain is a widely accepted concept. While there has been much focus on this in recent years, studies investigating obstructive sleep apnoea (OSA) and chronic pain are still not very common, especially in context of continuous positive airway pressure (CPAP) therapy. In this study, people recently diagnosed with OSA, a common sleep disorder, that are receiving a CPAP mask are asked to fill in questionnaires at baseline, 3- and 6-month follow-up. Data of people with and without chronic pain will be collected and we will use the data will allow us to answer a number of clinically relevant questions. The primary questions investigate the following: 1) The association of CPAP adherence and pain outcomes with CPAP therapy at 3-month follow-up; 2) The association of baseline Apnoea-Hyopnea-Index on pain outcomes with CPAP therapy at 3-month follow-up. Se

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Participants must be 18 years of age or older * Participants must be able to read and write in Dutch, French or English * Participants must be diagnosed with clinically relevant OSA and newly start CPAP treatment: * AHI ≥ 15 * Prescribed CPAP for the first time as a treatment for their OSA * Participants must have read and signed the ICF Exclusion Criteria: * Participants who are currently receiving CPAP treatment or have had a CPAP treatment in the last year * Participant receiving CPAP for other conditions than OSA (e.g. Central Sleep Apnoea)
💊

What it tests

  • Standard OSA care
📍

Where

1 site
Universitair Ziekenhuis Brussel
Brussels, Belgium
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy